Kash Patel Becomes the Focus of Media Analysis They Consistently Get Wrong
How America Has Destroyed Its Democracy, Part Two: The Aristocracy of Merit
Three Congressional Missteps on Healthcare
Today’s Qualifications to Be President of the U.S.
Climate Alarmists Howl After EPA Rescinds ‘Endangerment Finding’
Ukraine's Bureaucrats Are Finishing What China Started
Rising Federal Debt: Why Strategic Planning Matters More Than Ever for High-Net-Worth Fami...
Classroom Political Activism Shifts a Teacher’s Role from Educator to Indoctrinator
As America Celebrates 250, We Must Help Iran Celebrate Another 2,500
Guatemalan Citizen Admits Using Stolen Identity to Obtain Custody of Teen Migrant
Oregon-Based Utility PacifiCorp Settles for $575M Over Six Devastating Wildfires
Armed Man Rammed Substation Near Las Vegas in Apparent Terror Plot Before Committing...
DOJ Moves to Strip U.S. Citizenship From Former North Miami Mayor Over Immigration...
DOJ Probes Three Michigan School Districts That Allegedly Teach Gender Ideology
5th Circuit Vacates Ruling That Blocked Louisiana's Mandate to Display 10 Commandments in...
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order
AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement